4136

524396

BIOFILCHEM

img img img img
No Data Available

BIOFIL CHEM & PHARMA LTD Share Price Update

As of the latest trading session, BIOFIL CHEM & PHARMA LTD is trading at ₹34.22, up by ₹0.49 or 1.45% from its previous close. The stock has moved between ₹33.53 and ₹35.50 today. Over the past year, the stock has delivered a return of -25.07%. In the last month, it has returned 21.63%.

BIOFIL CHEM & PHARMA LTD performance

Today’s low Today’s high
₹ 33.53 ₹ 35.50
₹ 34.60
52 week low 52 week high
₹ 25.60 ₹ 57.19
₹ 34.60
Open Price ₹ 33.72
Prev. Close ₹ 33.73
Volume (Shares) 12113.00
Total traded value ₹ 4.19
Upper Circuit ₹ 40.47
Lower Circuit ₹ 26.99
info

Investment Returns

Over 1 Month 21.63% Over 3 Months 14.88% Over 6 Months -13.20% Over 1 Year -25.07%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BIOFIL CHEM & PHARMA LTD fundamentals


  • Market cap (Cr) 56.30
  • P/E Ratio (TTM) 19.79
  • Beta 1.05
  • Book Value / share 13.09
  • Return on equity 1.12%
  • EPS (TTM) 1.70
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.08
info icon alternate text
  • Market cap (Cr) 56.90
  • P/E Ratio (TTM) 19.79
  • Beta 0.99
  • Book Value / share 13.09
  • Return on equity 1.12%
  • EPS (TTM) 1.70
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.08
info icon alternate text

BIOFIL CHEM & PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 0.86
Operating Expense 0.83
Net Profit 0.08
Net Profit Margin (%) 9.30
Earnings Per Share (EPS) 0.05
EBITDA 0.18
Effective Tax Rate (%) 27.27
Particulars SEP 2025 (Values in Cr)
Revenue 13.54
Operating Expense 13.49
Net Profit 0.08
Net Profit Margin (%) 0.59
Earnings Per Share (EPS) 0.05
EBITDA 0.18
Effective Tax Rate (%) 27.27
Particulars JUN 2025 (Values in Cr)
Revenue 6.43
Operating Expense 6.50
Net Profit 2.41
Net Profit Margin (%) 37.48
Earnings Per Share (EPS) 1.48
EBITDA 2.83
Effective Tax Rate (%) 12.68
Particulars MAR 2025 (Values in Cr)
Revenue 8.35
Operating Expense 8.34
Net Profit 0.20
Net Profit Margin (%) 2.39
Earnings Per Share (EPS) 0.12
EBITDA 0.34
Effective Tax Rate (%) 20.00
Particulars DEC 2024 (Values in Cr)
Revenue 14.20
Operating Expense 14.00
Net Profit 0.16
Net Profit Margin (%) 1.12
Earnings Per Share (EPS) 0.10
EBITDA 0.33
Effective Tax Rate (%) 27.27
Particulars MAR 2025 (Values in Cr)
Revenue 33.40
Operating Expense 32.97
Net Profit 0.56
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 0.34
EBITDA 1.16
Effective Tax Rate (%) 24.32
Particulars MAR 2024 (Values in Cr)
Revenue 40.04
Operating Expense 39.66
Net Profit 0.71
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 0.44
EBITDA 1.31
Effective Tax Rate (%) 18.39
Particulars MAR 2023 (Values in Cr)
Revenue 30.04
Operating Expense 29.34
Net Profit 0.56
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 0.29
EBITDA 1.26
Effective Tax Rate (%) 29.11
Particulars MAR 2022 (Values in Cr)
Revenue 22.38
Operating Expense 21.52
Net Profit 0.70
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.44
EBITDA 1.48
Effective Tax Rate (%) 31.68
Particulars MAR 2021 (Values in Cr)
Revenue 35.75
Operating Expense 34.63
Net Profit 1.24
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.76
EBITDA 2.40
Effective Tax Rate (%) 35.41
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.54
ROE % 1.12
ROCE % 1.55
Total Debt to Total Equity 0.02
EBITDA Margin 3.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.19
ROE % 1.42
ROCE % 1.81
Total Debt to Total Equity 0.03
EBITDA Margin 3.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.63
ROE % 1.12
ROCE % 1.65
Total Debt to Total Equity 0.03
EBITDA Margin 4.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.35
ROE % 1.40
ROCE % 2.11
Total Debt to Total Equity 0.03
EBITDA Margin 6.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.91
ROE % 2.49
ROCE % 3.92
Total Debt to Total Equity 0.05
EBITDA Margin 6.71
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 50.96
Total Liabilities 50.96
Total Equity 18.78
Share Outstanding 1
Price to Book Ratio 3.56
Return on Assets (%) 1.09
Return on Capital (%) 2.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 47.08
Total Liabilities 47.08
Total Equity 18.20
Share Outstanding 1
Price to Book Ratio 5.39
Return on Assets (%) 1.50
Return on Capital (%) 3.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 31.40
Total Liabilities 31.40
Total Equity 17.30
Share Outstanding 1
Price to Book Ratio 3.90
Return on Assets (%) 1.78
Return on Capital (%) 3.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 18.73
Total Liabilities 18.73
Total Equity 16.83
Share Outstanding 1
Price to Book Ratio 5.58
Return on Assets (%) 3.72
Return on Capital (%) 4.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.23
Total Liabilities 33.23
Total Equity 16.12
Share Outstanding 1
Price to Book Ratio 6.62
Return on Assets (%) 3.73
Return on Capital (%) 7.5
Particulars MAR 2025 (Values in Cr)
Net Income 0.73
Cash from Operations -1.74
Cash from Investing -0.10
Cash from Financing 0.00
Net change in Cash -2.02
Free Cash Flow -1.64
Particulars MAR 2024 (Values in Cr)
Net Income 0.86
Cash from Operations 2.54
Cash from Investing -0.02
Cash from Financing -0.12
Net change in Cash 2.24
Free Cash Flow 2.57
Particulars MAR 2023 (Values in Cr)
Net Income 0.79
Cash from Operations 0.12
Cash from Investing -0.01
Cash from Financing 0.01
Net change in Cash -0.10
Free Cash Flow 0.13
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 0.09
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.29
Free Cash Flow 0.16
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.78
Cash from Investing -0.09
Cash from Financing -0.83
Net change in Cash 0.18
Free Cash Flow 2.35
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.76 15.05 1.80 266.38 23.12 40.44
BLISS GVS PHARMA LTD 273.70 26.17 2.55 2895.44 105.05 277.80
CIPLA LTD 1317.15 22.38 3.23 106397.09 1165.55 1672.20
FERMENTA BIOTECH LIMITED 314.25 10.45 2.36 924.87 252.15 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2445.10 41.18 24.25 41421.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.76 33.42 4.84 266.38 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 581.15 29.06 4.91 1680.14 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8576.10 103.07 26.83 21440.25 7630.00 10653.05
BLISS GVS PHARMA LTD 273.70 37.29 2.62 2895.44 105.05 277.80

BIOFIL CHEM & PHARMA LTD shareholding pattern

Holding
53.12%
46.79%
0.08%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BIOFIL CHEM & PHARMA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
34.60 2.57 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 33.70
  • 26 Days 32.50
  • 10 Days 33.50
  • 50 Days 32.50
  • 12 Days 33.30
  • 100 Days 33.80
  • 20 Days 32.70
  • 200 Days 37.60
33.68 PIVOT
First Support 33.36 First Resistance 34.04 Second Support 33.00 Second Resistance 34.36 Third Support 32.68 Third Resistance 34.72
RSI 57.55 ADX 22.45 MACD 0.82 Williams % R -37.03 Commodity Channel Index (CCI) 43.05
Date 2026-04-27 Week 8294.00 Same Day 2297.00 Month 16553.00
1 Year 1.05 3 Year 1.22
Over 1 Month
21.63% down
Over 1 Year
-25.07% down
Over 3 Months
14.88% down
Over 3 Years
-8.16% down
Over 6 Months
-13.20% down
Over 5 Years
-15.46% down

BIOFIL CHEM & PHARMA LTD Corporate Actions

Top Gainers

Top Losers

BIOFIL CHEM & PHARMA LTD Share Price

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.

In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL.

Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products.

Parent organization Systematix
NSE symbol BIOFILCHEM
Founded 1985
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

Biofil Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 34.22 & for BSE ₹ 34.99 as on Apr 28 2026 03:30 PM.

What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Biofil Chemicals & Pharmaceuticals Ltd for NSE ₹ 56.30 & for BSE ₹ 0.00 as on Apr 28 2026 03:30 PM.

What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 57.19 and ₹ 25.60 and for BSE is ₹ 56.36 and ₹ 25.60.

What is 1 year return for Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -25.07%.

What is the P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Apr 28 2026 03:30 PM the price-to-earnings (PE) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 19.79.

What is the PB ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Apr 28 2026 03:30 PM, the price-to-book (PB) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 13.09.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Biofil Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Biofil Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Biofil Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|